XML 30 R20.htm IDEA: XBRL DOCUMENT
v3.22.1

Warrants | 3 Months Ended
--- | ---
Mar. 31, 2022
Warrants. |
Warrants | 13. Warrants In January 2021, in connection with a Business Development Agreement entered into with Finback Evolv II, LLC (“Finback BDA”), the Company issued a warrant to Finback for the purchase of 2,552,913 shares of common stock at an exercise price of $0.42 per share. The 2021 Finback common stock warrants vest upon meeting certain sales criteria as defined in the agreement and expires in January 2031. The warrants will be accounted for under ASC 718 Compensation – Stock Compensation as the warrants will vest upon certain performance conditions being met (see Note 16). ​ In connection with the closing of the Merger, the Company assumed the Public Warrants for the purchase of 14,325,000 shares of common stock at an exercise price of $11.50. The Public Warrants are immediately exercisable and expire in July 2026. The Public Warrants are classified as a liability and were recorded at its fair value of $23.6 million on the date of the closing of the Merger with an offset to additional paid-in-capital and is subsequently remeasured to fair value at each reporting date based on the publicly available trading price. The change in fair value of the public warrant liability of $5.6 million and $0 was recognized as a component of other income (expense), net in the condensed consolidated statements of operations and comprehensive loss for the three months ended March 31, 2022 and 2021, respectively. As of March 31, 2022, none of the vested 2021 Finback common stock warrants were exercised. ​ As of March 31, 2022 and December 31, 2021, warrants to purchase the following class of Common stock outstanding consisted of the following in the tables below: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
March 31, 2022
​ | ​ | Contractual | ​ | ​ | ​ | ​ | ​ | Shares Issuable | ​ | Weighted
​ | ​ | Term | ​ | Underlying Equity | ​ | Balance Sheet | ​ | Upon Exercise | ​ | Average
Issuance Date |  | (in years) |  | Instrument |  | Classification |  | of Warrant |  | Exercise Price
January 13, 2021 |  | 10 |  | Common stock |  | Equity |  | 2,552,913 | ​ | $ | 0.42
July 16, 2021 |  | 5 |  | Common stock |  | Liability |  | 14,324,993 | ​ | $ | 11.50
​ | ​ | ​ |  |  |  |  |  | 16,877,906 | ​ |  |
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
December 31, 2021
​ | ​ | Contractual | ​ | ​ | ​ | ​ | ​ | Shares Issuable | ​ | Weighted
​ | ​ | Term | ​ | Underlying Equity | ​ | Balance Sheet | ​ | Upon Exercise of | ​ | Average
Issuance Date |  | (in years) |  | Instrument |  | Classification |  | Warrant |  | Exercise Price
January 13, 2021 |  | 10 |  | Common stock |  | Equity |  | 2,552,913 | ​ | $ | 0.42
July 16, 2021 |  | 5 |  | Common stock |  | Liability |  | 14,324,994 | ​ | $ | 11.50
​ | ​ | ​ |  |  |  |  |  | 16,877,907 | ​ |  |
​

X
- Definition The entire disclosure related to warrants and rights. + References No definition available. + Details
Name: | nhic_WarrantsAndRightsNoteDisclosureTextBlock
Namespace Prefix: | nhic_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_WarrantsAndRightsNoteDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration